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Abstract The class of Ca2+-permeable cation channels is
composed of large families with six transmembrane segments
including transient receptor potential, vanilloid receptor (VR),
polycystin, epithelial calcium channels and melastatin (MLS).
However, most of them are functionally silent and unexpressed in
mammalian cells. An investigation of associated proteins made us
believe that the blockade of calpain opens the silent channels.
Using 1 WM of blockers in whole cellular patch pipette fill we
measured currents of Chinese hamster ovary cells transfected by
VR-like 1 and 2, polycystin-2, or a MLS-like new member
(MLS3S). Significant conductance of every clone with a
characteristic rectification by blockers was demonstrated. The
permeability of Ca2+ to them is similar to that reported. Western
blot suggested that blockers did not affect the assembly of the
protein but enabled its cleavage. Therefore, investigation of these
families with the blockers may boost our knowledge of
electrophysiologic function. ß 2002 Published by Elsevier Sci-
ence B.V. on behalf of the Federation of European Biochemical
Societies.
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1. Introduction
In£ux of Ca2 into cells is a fundamental process and is
widely observed in physiologic or pathophysiologic phenom-
ena. The Ca2 permeability is achieved as a cation £ow, which
does not precisely discriminate between monovalent and diva-
lent cations. Ca2 permeability is driven through the cation
channel and activated by voltage, ligand, or mechanical stress.
The voltage-independent, ligand-gated, non-selective cation
currents are widely observed and encoded by large molecular
families including transient receptor potential (TRP) [1^5],
vanilloid receptor (VR) [6], epithelial calcium channel
(ECaC) [9^11] and polycystins [12^16]. All of these possess
six transmembrane segments (TMSs) and a putative pore re-
gion between the ¢fth and sixth TMS with a unique N-termi-
nal. Most of these channels are weakly expressed in common
organisms, e.g. as in mammalian cells or Xenopus oocytes, and
that limits the systems in which we can explore knowledge of
their physiologic functions.
Drosophila photoreceptors provide a ¢rst clue to investigat-
ing the TRP cation channel. TRP reveals six TMSs with a
pore, the structure of which is similar to the voltage-depen-
dent K channel family. TRP is coupled with Gq protein and
requires metabolites of inositol phosphates for activation [1^
4]. TRP currents appeared after removal of intracellular Ca2
or Ca2-store depletion with thapsigargin [5]. Using expres-
sion cloning, the six TMSs are generated in higher quantity.
VR (VR1), cloned by employing a capsaicin-induced rise in
intracellular calcium, is another example of cation channel
with six TMSs [6]. Physical or chemical irritants (or insulin)
are required to open the VR family [7,8]. On the other hand,
six TMSs were also discovered in analysis of disease. Genes
corresponding to polycystic kidney disease show PKD1 and 2
[12,13]. Especially, PKD2 shows a similar structure to six
TMSs. PKDL, a family of PKD but unrelated to disease,
has a cation channel expressed [16]. Melastatin (MLS) has
been cloned by a di¡erential display unique in melanocytes
metastasis [17,18]. MLS family distributes widely and reveals
a similar structure but its function remains obscure. An ex-
ception is the ECaC family, which opens as a highly Ca2-
permeable channel and is only expressed in mammalian Chi-
nese Hamster ovary (CHO) cells [11]. The reason for the func-
tional silence for most of the clones above is unknown. One
explanation is found in the requirement for an associated
protein that introduces channels toward the membrane sur-
face. Another reason might possibly be an intracellular mam-
malian speci¢c regulatory protein which may inhibit ion per-
meation of these channels. Because of the high degree of
expression of channel molecule in these cells, the associated
proteins should be abundant in situ.
During an investigation of associated proteins, we found
frequent binding of an enzyme, protease, to the C-terminal
adjacent to sixth TMS of VR-like SIC channel [19]. Genomic
analysis revealed that VR-like 2 (AB021875) is more appro-
priate for doing further analysis than SIC, since VRl2 as well
as VRl1 have homology to VR1. Using the following cDNA
clones: VRl1 (AB022332) and VRl2, MLS-like clones
(MLS3), and human PKD2, we explored their functional
expressions by modifying this enzyme in mammalian CHO
cells.
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2. Materials and methods
2.1. Two-hybrid screening
To investigate associated proteins of a VR family member (VRl2),
the C-terminal amino acid (A.A. #736-end) was employed as bait for
binding proteins from a mouse kidney library by yeast two-hybrid
screening (Clontech, Matchmaker ver. 2, CA, USA).
2.2. Expression of cDNA and detection of the VRl2 protein
The cloned cDNAs (VRl1 and VRl2) were ligated to the mamma-
lian expression vector, pCMV-SPORT (Gibco-BRL, MD, USA). Hu-
man PKD2 cDNA was inserted into pCEP4 (Invitrogen, MD, USA).
Six-histidine-tag was added to the C-terminal using a pHM6 vector
(Roche Molecular Biochemicals, Germany). Northern blot, Western
blot, and the expression in Xenopus oocytes were performed as pre-
viously described [20]. The membrane fraction of the oocytes (0.1 mg)
was incubated with Ca-dependent protease (5 U/ml, Sigma, St. Louis,
MO, USA) in bu¡er containing 10 mM dithiothreitol, 10% glycerol,
100 mM HEPES, 1 mM ATP and 5 mM CaCl2 for 3 h at 37‡C. The
reaction was modi¢ed by incubation either with calpastatin (0.1 mM),
leupeptin (1 mM), E64 (1 mM) or EGTA (5 mM). A part of the
samples was loaded to SDS-denatured acrylamide gel, in which
VRl2 was detected by an antibody against the C-terminal
(PKWRTDDAPL). The speci¢city of this antibody was determined
by using an excess amount of antigen.
To obtain VRl2-expressed membrane of mammalian cells, CD4 and
VRl2 were co-transfected to CHO cells. They were incubated with 10
WM dE64 (membrane-permeable E64) in bath solution containing 140
mM NaCl, 1 mM MgCl2, 3 mM HEPES (pH 7.4) with 5 mM CaCl2
for 1 h. The cells were homogenized by 10 strokes and centrifuged at
5000Ug for 10 min in 0.3 M sucrose, 25 mM imidazole, 1 mM
EDTA, and 1 mM PMSF. The supernatant was incubated with
anti-CD4 antibody-coated glass-beads (Dynabeads M-450, Dynal,
Oslo, Norway) for 20 min at room temperature. The CD4-positive
membrane fraction was then collected by brief centrifugation
(5000Ug for 1 min) and dissolved in RIPA (150 mM NaCl, 50 mM
Tris pH 7.4, 0.05% NP40, and 0.1% SDS). The sample of 0.01 mg was
loaded to an SDS-denatured gel, in which VRl2 and CD4 were de-
tected by anti-His antibody (anti-His6 HRP, Invitrogen) and anti-
CD4 antibody (CD4 Ab2, NeoMarkers, CA, USA), respectively.
The immune complex was detected by ECL1 (Amersham, OH, USA).
Fig. 1. Molecules examined in this study. a: Hydropathy plot of VRl1, VRl2, PKD2, MLS3L, and MLS3S reveals putative six TMSs (1^6) by
Kyte^Doolittle. A.A.: amino acid number. b: Northern blot analysis of the expression of MLS3 mRNA was performed. Full-length cDNA
was used as a probe. 2 Wg of total RNA from mouse tissues was charged per lane. The migration positions of rRNA are indicated on the left.
Arrows indicate long MLS3L around 5 kb and short MLS3S around 3 kb. c: Cloned amino acids alignment of the binding protein to VRl2
C-terminal in mouse kidney library. Line indicates a common alignment of an active center of Ca-dependent protease.
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2.3. Electrophysiology
Patch clamp recordings were carried out according to methods de-
scribed previously [11,19]. The GFP-positive cells were visualized by
£uorescence measurement (CAM 2000 System, Jasco, Tokyo, Japan)
with an emission of 490 nm. Currents were recorded at room temper-
ature with an EPC-9 patch clamp ampli¢er (HEKA, Pfalz, Germany).
Applied voltage and sampling were controlled by a computer system
(HEKA, Pfalz, Germany). The bath solution contained 140 mM
NaCl, 1.0 mM MgCl2, 1.0 mM CaCl2, and 3 mM HEPES (pH 7.4).
The whole-cell patch pipette contained a ¢ltered solution of 150 mM
CsCl, 1 mM EGTA (Ca2 = 200 nM adjusted by CaCl2 to mimic
intracellular milieu), and 3 mM HEPES (pH 7.2). The bath solution
was substituted with 100 mM NMDGCl/40 mM NaCl, or with 100
mM Na aspartate/40 mM NaCl to calculate the permeability ratio of
NMDG or Cl3. To measure the Ca2 over Cs permeability ratio,
the bath solution underwent substitution with 50 mM CaCl2, and
3 mM HEPES. The permeability ratio was calculated as described [21].
PCa=PCs  sKCsCsIfexpErevF=RT1 expErevF=RTg
=4KCaCao KCs  0:75; KCa  0:25 :
3. Results
3.1. Cloning of channels
VRl2 was cloned from speci¢c SIC C-terminal alignment as
a probe from a mouse kidney cDNA library. VRl2 was de-
tected in lung and kidney by Northern blot. The BLAST
program searched homology of Trp-like transmembrane
alignment, resulting in an MLS-like structure with TRP7-
like TMSs (accession numbers AK000235, AK000048) [22].
Fig. 3. Representative traces of cation channels. Whole cellular currents during voltage steps ranging from 3100 mV to 30 mV (increment of
10 mV; holding potential 0 mV; duration of stimulation 100 ms) following expression of GFP marker (MOCK), and genes of interest (VRl2,
PKD2, MRL3s) in CHO cells were recorded by patch clamp. Pipette contained 1 WM calpastatin for VRl2 and 1 WM leupeptin for MOCK,
PKD2 and MRL3s. VRl2+GdCl3: GdCl3 at 0.1 mM was added to VRl2 channel. Magnitude of the current is set to the scale provided in the
center.
Fig. 2. Calpain-dependent cleavage of VRl1 and VRl2 and in£uence
of E64d. a: VRl2-expressed Xenopus oocyte membrane was incu-
bated with 5 mM CaCl2, 10 WM calpain inhibitors (lanes 2^4) or
5 mM EGTA for 3 h. VRl2 protein was detected by C-terminal
antibody. Closed arrow indicates VRl2 protein and open arrow indi-
cates a non-speci¢c protein, which remained after incubation with
an excess amount of antigen. b: In£uence of cell-permeable calpain
blocker, dE64, on the expression of VRl2 was examined. VRl2-ex-
pressed CHO cells were incubated with 5 mM CaCl2, or 10 WM
dE64 for 1 h (lanes 1 and 2) and 3 h (lanes 3 and 4). VRl2 protein
was detected by anti-His6 antibody. Arrow indicates VRl2 corre-
sponding bands, monomer, dimer and tetramer (upper panel). The
membrane protein, CD4, was concomitantly detected by anti-CD4
antibody. Arrow indicates the corresponding band (lower panel).
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These two clones, named MLS3S and MLS3L in the present
study, were purchased from Takara Co. (Osaka, Japan). The
hydropathy of the channels examined here is aligned for com-
parison (Fig. 1a). All the channels have putative six TMS with
a possible pore region between the ¢fth and sixth TMS. MLS3
is highly expressed in the gastrointestinal tract and possesses
two isoforms, 5 kb (MLS3L) and 3 kb (MLS3S), by Northern
blot analysis (Fig. 1b).
3.2. Interaction of the protease and VRl1 and VRl2
Duplicated screenings for binding proteins for C-terminal
were examined, resulting in 80 positive clones. The majority of
their sequences were equivalent to proteins in the nucleus or
mitochondria, three to unknown enzymes and two to the fol-
lowing enzymes: aldehyde reductase and calpain. The se-
quence of the clone (Fig. 1c) revealed it to be homologous
to an active center of the Ca2-dependent cysteine protease,
calpain. Potency of GAL4 promoter was estimated by L-ga-
lactosidase activity under the manufacturer’s protocol (ONPG
method). Co-expression of the bait and the clone resulted in
56 units as compared to 10 in the negative control.
Various forms of the enzyme (CAPN1^13) have been ex-
tensively studied. Since the clone was only a fragment of the
catalytic domain, we could not identify which molecule it was
of this family [23,24]. Calpain is activated at a Ca2 concen-
tration which exceeds that necessary to digest a target protein.
Several speci¢c blockers are useful: calpastatin, leupeptin, and
E64 were employed in the present study. Since many associ-
ated proteins may modify the cleavage in mammalian cells,
the membrane fraction of VRl2-expressed Xenopus oocytes
was used. It was incubated with calpain for 0.5, 1 and 3 h
at 37‡C. The cleavage of this protein was detected at 3 h by
C-terminal antibody and protection of this cleavage was
achieved with either calpastatin, leupeptin, E64 or EGTA
(Ca free) (Fig. 2a). Thus VRl2 (and VRl1, data not shown)
becomes a substrate for degradation by the enzyme. Further,
to elucidate the e¡ect of the blocker in CHO cells on VRl2
expression, tag-protein was added to enhance sensitivity of
detection. The VRl2-transfected cultures were incubated
with or without cell-permeable E64d (10 WM, 1 h and 3 h)
in bath solution. CD4 is an antigen expressed in the mem-
brane. Using CD4 as a marker to purify the plasma mem-
Fig. 4. Current^voltage relations of cation channels during substitution of bath solution. Mean normalized currents are plotted to voltage in
NaCl (open circle), to CaCl2 (closed triangle) bath solution through NMDGCl (closed circle) and Na aspartate (open triangle). Pipette con-
tained 1 WM calpastatin for VRl2 (n = 8) and 1 WM leupeptin for MOCK (n = 4), PKD2 (n = 8) and MRL3s (n = 8). MOCK was the current in
CHO cells transfected by GFP marker £uorescence in pipette containing 1 WM E64. Open diamond indicates current in the pipette free from
any blockers (n = 4).
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brane, the VRl2 expressed on the membrane was isolated
from the whole cellular extracts. We tried to compare the
density and ratio of VRl2/CD4 before and after treatment
with dE64. The treatment, however, did not in£uence the
amount of expression or the assembly of their subunits on
the membrane in six repeated detections (Fig. 2b).
3.3. Expression of the ligand-gated channel families with
blockers
The opening of these channels with the blockers is shown in
Fig. 3. The control basal current without the blockers was
measured in VRl1-, VRl2- MLS3S- or PKD2-transfected
CHO cells. All of the basal currents £uctuated within þ 0.2
nA in the voltage range from 3100 mV to 100 mV with 10^30
pF cells. Thus we judged that they did not open in this setting.
When pipette solution contained calpastatin (1 WM) or leu-
peptin (1 WM), a signi¢cant current appeared within 1 min. In
GFP-transfected control cells, outward-recti¢ed current was
noticed but not ampli¢ed over þ 1 nA. The current was driv-
en by Cl3, since substitution of Cl3 with aspartate shifted the
reversal potential (Vrev) to positive (20 mV6 ) and addition of
0.1 mM Gd3 did not in£uence the current (n = 4). VR1 and
VRl2 revealed outward-recti¢ed currents driven by Na/Cs,
and this is characteristic of this family. The magnitude of the
current was over þ 2 nA, and it was completely blocked by
0.1 mM Gd3 and not in£uenced by substitution of the anion.
PKD2 showed a large current without a time-dependent com-
ponent. On the other hand, MLS3S showed time-dependent
fast decay, which is characteristic in the Trp family and in
CCE (capacitive calcium entry) [3^5,22]. Both openings were
blunted by 0.1 mM Gd3.
Next, current^voltage relations and ion selectivity of these
channels were examined (Fig. 4, Table 1). The bath solution
was changed from NaCl to CaCl2 by using NMDGCl and Na
aspartate. Reversal potentials of these currents were altered
during the substitution of the solutions. These voltages of
eight experiments in each channel provided PX/PCs as sum-
marized in Table 1. PKD2 showed less selectivity to both
cations and anions, as compared to the other three. After
the measurement, the currents driven by cations were abol-
ished by addition of GdCl3. If the current was not abolished
(resistance over 100 M6), the data were discarded.
The opening of a channel may not be related to the kind
of blocker. For VRl2, calpasatatin was the primary opener
selected, giving 18 openings on 20 patches. The following
two trials (with leupeptin or E64) provided successful open-
ings (two openings on two patches). We thus considered cal-
pasatatin to be the primary opener. In the same way, leupep-
tin for VRl1 and PKD2, and E64 for MLS3 were primary
openers. We used the primary openers to obtain the results
in Table 1.
4. Discussion
Among the binding proteins to VRl2, we found a candi-
date, calpain, which modi¢es their function. The blockers are
highly speci¢c to the enzyme [23]. However, the e¡ect on the
cation channel appeared to be non-speci¢c, since the blockers
activated unrelated but structurally similar molecules, PKD2
and MLS3, in addition to a related molecule, VRl1. Further-
more, the blockers altered the current in untransfected^basal
control. CHO cells generally revealed a little underlying Cl3
current in the present setting. The current was exaggerated by
using the blocker. Therefore, discrimination between the ex-
pressed and underlying current is very important. The under-
lying current was driven by Cl3 as suggested by the ion sub-
stitution study. Most of the current was blocked by 0.1 mM
£ufenamate, but not altered by 0.1 mM GdCl3. It did not
exceed 1 nA (normalized current of 0.05 nA/pF). Current^
voltage relation of the underlying current was slightly out-
wardly recti¢ed. VRl2 and VRl1 showed similarly recti¢ed
currents. They were, however, completely blocked by 0.1
mM GdCl3 and their reversal potential was not a¡ected by
substitution of the anion. We can therefore identify the open-
ing by the magnitude of the current and the blockade of
GdCl3 added after the measurement.
We thought that the blocker might open an endogenous
cation channel. That appeared unlikely however, since
PKD2 opened by the blocker revealed its own characteristics
such as linear current^voltage and poor selectivity for NMDG
[14,15]. Generally, expression of PKD2 has not been achieved
in mammalian cells. PKD1 is required to open the PKD2
channel [15]. Otherwise, PKD2 successfully expresses in insect
cells [14]. Both reports [14,15] represent an electrophysiologic
characteristic similar to the present results. Therefore, calpain
opened the exogenous PKD2 cDNA rather than the modi¢ed
endogenous ones.
MLS is a gene which has not been expressed as a channel in
mammalian cells. The structure with six TMSs is similar to
that of the Trp family. MLS, however, has a characteristic
long N-terminal, though it is not known to have function as
a channel. Likewise, VRl1, VRl2, and PKD2 have six TMSs
with a hydrophobic long N-terminal. We found that the TMS
of MLS3 had a signi¢cant homology to Trp7 and its N-ter-
minal had a homology to MLS. MLS3S lacks the long N-ter-
minal and co-localizes with its long form in intestine and
colon. We tried to detect current in CHO cells with co-trans-
fection of the two clones, but failed to detect a signi¢cant
(over 0.5 nA at 3100 mV) current (n = 6, data not shown).
Thus we do not ¢nd a meaning in the presence of the two
forms, MLS3L and S. One of the characteristics of Trp7 cur-
rents is a time-dependent rapid decay [22], which was ob-
served in the expression of MLS3S in the present study.
Thus MLS might become a channel with a certain stimulus
or milieu.
The mechanism of the opening by the blocker is not known,
but it at least involves a cleavage of C-terminal by the en-
zyme. VRl1 and VRl2 were cleaved by calpain but the time
course of the functional activation and biochemical cleavage
was quite di¡erent. We tried to detect another possibility that
the blocker modi¢ed the expression toward the membrane or
assembly of the subunit. We note that the histidine-tagged
protein gains resolution to identify the labeled protein [25].
Thus we employed this strategy to clarify this possibility.
Table 1
Permeability ratio over Cs of cation channels
Na NMDG Cl Ca
VRl2 1.1 0.016 0.016 9
VRl1 0.9 0.016 0.016 9
PKD2 1.1 1 0.1 4.8
MLS3S 2.2 0.016 0.016 4
Permeability ratio is calculated by mean reversal potentials during
substitution of the solution (n = 8).
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However, the results did not suggest this possibility. Even
with the negative results, there are still other possibilities
than cleavage underlying the mechanism of the activation.
Our hybrid study that suggests the fact that the active center
of calpain binds to C-terminal alignment might be used to
argue that degrades would be less than 30 Kd by using the
C-terminal antibody. The cleavage by calpain of VRl1 and
VRl2 revealed several degrades, of sizes higher than expected.
Since the C-terminal of VRl2 is a site to bind calpain, we
made N- or C-terminal deleted mutants. Surprisingly, both
the mutants were able to induce the Gd3-sensitive outward-
recti¢ed current when the pipette contained E64, though not
so frequently (4/10 in N-deleted and 2/10 in C-deleted mu-
tants, data not shown). Therefore, the mechanism of the
opening by the blockers still involves possibilities other than
protection of the cleavage by calpain.
There are some data that calpain regulates calcium in£ux
through voltage-dependent [26,27] NMDA receptor [28] and
leaky Ca2 entry [29]. The mechanism of run-down of vol-
tage-dependent Ca2 channel in heart involves calpain cleav-
age. The K-subunit is reported to be site-responsive to this
mechanism. However, several studies agree that proteolysis
is only partially responsible for the run-down, and therefore
unidenti¢ed factor(s) in the cytoplasm contribute to the mech-
anism [30]. Therefore, there might be factor(s) related to cal-
pain that up-regulate not only the voltage-dependent Ca2
channel but also the Ca2-permeable non-selective cation
channels and even possibly the underlying Cl3 channels. Ac-
tivation of the ligand-gated cation channel families by calpain
may be suggested by non-speci¢c Ca2 leakage as measured
by £uorescence dye [29]. However, none of the direct evidence
for this activation has been described at the molecular level.
As far as we know, this is the ¢rst report that blockers against
calpain are useful in the investigation of ligand-gated cation
channels when they are functionally silent, although the mo-
lecular mechanism or relevance to physiologic regulation re-
mains obscure.
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